» Articles » PMID: 38898420

Development and Validation of a Nomogram for Assessing Survival in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2024 Jun 19
PMID 38898420
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early prediction of survival of hospitalized acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients is vital. We aimed to establish a nomogram to predict the survival probability of AECOPD patients.

Methods: Retrospectively collected data of 4601 patients hospitalized for AECOPD. These patients were randomly divided into a training and a validation cohort at a 6:4 ratio. In the training cohort, LASSO-Cox regression analysis and multivariate Cox regression analysis were utilized to identify prognostic factors for in-hospital survival of AECOPD patients. A model was established based on 3 variables and visualized by nomogram. The performance of the model was assesed by AUC, C-index, calibration curve, decision curve analysis in both cohorts.

Results: Coexisting arrhythmia, invasive mechanical ventilation (IMV) usage and lower serum albumin values were found to be significantly associated with lower survival probability of AECOPD patients, and these 3 predictors were further used to establish a prediction nomogram. The C-indexes of the nomogram were 0.816 in the training cohort and 0.814 in the validation cohort. The AUC in the training cohort was 0.825 for 7-day, 0.807 for 14-day and 0.825 for 21-day survival probability, in the validation cohort this were 0.796 for 7-day, 0.831 for 14-day and 0.841 for 21-day. The calibration of the nomogram showed a good goodness-of-fit and decision curve analysis showed the net clinical benefits achievable at different risk thresholds were excellent.

Conclusion: We established a nomogram based on 3 variables for predicting the survival probability of AECOPD patients. The nomogram showed good performance and was clinically useful.

Citing Articles

Construction and Comparison of Multiple Serum-Based Prognostic Models for Predicting the Prognosis of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Wang N, Wang G, Li M, Liu T, Ji W, Hu T J Inflamm Res. 2024; 17:8395-8406.

PMID: 39534059 PMC: 11555031. DOI: 10.2147/JIR.S461961.

References
1.
Andreen N, Andersson L, Sundell N, Gustavsson L, Westin J . Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease. Infect Dis (Lond). 2022; 54(7):508-513. DOI: 10.1080/23744235.2022.2050422. View

2.
Luo Z, Zhang W, Chen L, Xu N . Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD. Int J Gen Med. 2021; 14:2839-2848. PMC: 8242126. DOI: 10.2147/IJGM.S312045. View

3.
Zhou Y, Bruijnzeel P, McCrae C, Zheng J, Nihlen U, Zhou R . Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics. J Thorac Dis. 2015; 7(4):720-33. PMC: 4419302. DOI: 10.3978/j.issn.2072-1439.2015.04.14. View

4.
Yao C, Liu X, Tang Z . Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:2285-2290. PMC: 5546734. DOI: 10.2147/COPD.S141760. View

5.
Zhou Z, Wang W, Li Y, Jin K, Wang X, Wang Z . In-depth mining of clinical data: the construction of clinical prediction model with R. Ann Transl Med. 2020; 7(23):796. PMC: 6989986. DOI: 10.21037/atm.2019.08.63. View